Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Article English OPEN

Marjan W Attaei, MA; Rasha Khatib, PhD; Prof Martin McKee, DSc; Prof Scott Lear, PhD; Prof Gilles Dagenais, MD; Ehimario U Igumbor, PhD; Khalid F AlHabib, MD; Prof Manmeet Kaur, PhD; Lanthe Kruger, PhD; Prof Koon Teo, PhD; Fernando Lanas, MD; Khalid Yusoff, MD; Aytekin Oguz, MD; Prof Rajeev Gupta, PhD; Afzalhussein M Yusufali, MD; Ahmad Bahonar, MD; Prof Raman Kutty, MD; Prof Annika Rosengren, MD; Prof Viswanathan Mohan, DSc; Prof Alvaro Avezum, PhD; Prof Rita Yusuf, PhD; Prof Andrzej Szuba, PhD; Sumathy Rangarajan, MSc; Clara Chow, PhD; Prof Salim Yusuf, DPhil; S Yusuf; S Rangarajan; K K Teo; C K Chow; M O'Donnell; ... view all 432 authors

(2017)

Publisher: Elsevier

Journal: Lancet Public Health (issn: 2468-2667)

Publisher copyright policies & self-archiving

Related identifiers: doi: 10.1016/S2468-2667(17)30141-X
Subject: RA1-1270 | Public aspects of medicine

Background: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medici... View more

References (36)
36 references, page 1 of 4
1
2
3
4
1 Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016; 388: 2665-712.
2 Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370: 591-603.
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Chow KC, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310: 959-68.
Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 2002; 4: 393-404.
James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-20.
WHO. The selection of essential drugs. 1977. http://apps.who.int/ medicinedocs/documents/s20185en/s20185en.pdf (accessed Sept 20, 2016).
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 2000; 342: 905-12.
Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol 2005; 42: 17-25.
N Engl J Med 2016; 374: 2009-20.
N Engl J Med 2016; 374: 2021-31.

Related Research Results (2)

Inferred

Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies (2014)	75%
Environmental Profile of a Community’s Health (EPOCH): An Ecometric Assessment of Measures of the Community Environment Based on Individual Perception (2012)	57%

Similar Research Results (4)

An assessment of possibilities for stronger inclusion of upper-middle-income economies in the fairtrade system : case study Serbia	79%
Tracking the middle-income trap: What is it, who is in it, and why? (2012)	79%
Changing for the Better : The Path to Upper-Middle-Income Status in Uzbekistan (2013)	71%
Changing for the Better: The Path to Upper-Middle-Income Status in Uzbekistan (2013)	71%

Metrics

Share - Bookmark

Download from
Lancet Public Health via DOAJ-Articles (Article, 2017)
LSHTM Research Online via CORE (RIOXX-UK Aggregator) (Article, 2017)
Elsevier/ Lancet Public Health
Cite this publication